
Technologies
The 12-Month Price Target For Inozyme Pharma Inc. (NASDAQ:INZY) Is Now $40.00.
In recent trading session, Inozyme Pharma Inc. (NASDAQ:INZY) saw 0.91 million shares changing hands at last check today with its beta currently measuring 0. Company’s